Evidence map›Paper›PMID 30564940›Full record

ArticleJournal of cheminformatics2018

A neural network approach to chemical and gene/protein entity recognition in patents.

Ling Luo, Zhihao Yang, Pei Yang, Yin Zhang, Lei Wang, Jian Wang, Hongfei Lin

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. DeIDNER Model: A Neural Network Named Entity Recognition Model for Use in the De-identification of Clinical Notes.Biomedical engineering systems and technologies, international joint conference, BIOSTEC ... revised selected papers. BIOSTEC (Conference) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ling LuoCollege of Computer Science and Technology, Dalian University of Technology, Dalian, China.ORCID http://orcid.org/0000-0002-5141-0259
Zhihao YangCollege of Computer Science and Technology, Dalian University of Technology, Dalian, China. yangzh@dlut.edu.cn.
Pei YangCollege of Computer Science and Technology, Dalian University of Technology, Dalian, China.
Yin ZhangBeijing Institute of Health Administration and Medical Information, Beijing, China.
Lei WangBeijing Institute of Health Administration and Medical Information, Beijing, China. wangleibihami@gmail.com.
Jian WangCollege of Computer Science and Technology, Dalian University of Technology, Dalian, China.
Hongfei LinCollege of Computer Science and Technology, Dalian University of Technology, Dalian, China.

Funding

Ministry of Education of China NCET-13-0084Ministry of Science and Technology of China 2016YFC0901902National Natural Science Foundation of China 61272373National Natural Science Foundation of China 61572098National Natural Science Foundation of China 61572102
6 · The paper itself

Abstract

In biomedical research, patents contain the significant amount of information, and biomedical text mining has received much attention in patents recently. To accelerate the development of biomedical text mining for patents, the BioCreative V.5 challenge organized three tracks, i.e., chemical entity mention recognition (CEMP), gene and protein related object recognition (GPRO) and technical interoperability and performance of annotation servers, to focus on biomedical entity recognition in patents. This paper describes our neural network approach for the CEMP and GPRO tracks. In the approach, a bidirectional long short-term memory with a conditional random field layer is employed to recognize biomedical entities from patents. To improve the performance, we explored the effect of additional features (i.e., part of speech, chunking and named entity recognition features generated by the GENIA tagger) for the neural network model. In the official results, our best runs achieve the highest performances (a precision of 88.32%, a recall of 92.62%, and an F-score of 90.42% in the CEMP track; a precision of 76.65%, a recall of 81.91%, and an F-score of 79.19% in the GPRO track) among all participating teams in both tracks.

Indexed as

Biomedical entity recognitionConditional random fieldDeep learningLong short-term memoryPatents

Identifiers

PMID30564940
PMCPMC6755562

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.